Albumin levels in urine, a marker for renal glomerular damage, were measured after eight days, one and a half, respectively, six months post-injection in non-tumor bearing animals and after three- and 28-days post-injection in mice with LNCaP tumors. Here, ALB is linked to neoplasm.